HRID1043602

反应详情

EQUATION

反应方程式

HRID 1043602 的结构方程式

PROCEDURE

实验过程

4-(2-chloro-6-((4-(oxetan-3-yl)piperidin-1-yl)methyl)pyrido[3,2-d]pyrimidin-4-yl)morpholine (0.11 g) was reacted with 1-(tert-butyldimethylsilyl)-5-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole via General Procedure A to produce 59.8 mg of 130 following reverse phase HPLC purification. MS (Q1) 503.3 (M)+

WORKUP

后处理

  1. customto produce
  2. custom59.8 mg of 130 following reverse phase HPLC purification